Provalis Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
FDA clears firm's 510(k) Aug. 21 for Glycosal HbA1c, a four minute, point-of-care diabetes monitoring test that measures glycated hemoglobin. The product has also been recently approved in Japan, where BioRad Laboratories will market it as the Micromat II